e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 15

Cancer cachexia: molecular basis and therapeutic advances

Yuting Tan; Rui Xue; Yuwei Pan; zongsheng he; Xiao Hu; Yaping Li; Ke Li; Xuan Zhang · 2026 · Signal Transduction and Targeted Therapy

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

The dynamic interplay between neoplastic cells and the host has been increasingly recognized as important players in the pathogenesis of cancer cachexia, a syndrome affecting ~50-80% of cancer patients with various incidences of different types of malignancies. Despite its prevalence, a comprehensive understanding of cancer cachexia progression, with a holistic view at the cross-organismal, cellular and molecular levels, remains elusive. In this review, we undertake an in-depth exploration of the relevant target organs and their regulatory roles in cancer cachexia, with a particular focus on m

Abstract by Yuting Tan; Rui Xue; Yuwei Pan; zongsheng he; Xiao Hu; Yaping Li; Ke Li; Xuan Zhang, Signal Transduction and Targeted Therapy (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41392-025-02331-7